Laboratory investigations performed in the subjects
| Individuals in each diagnostic category having investigations | Mean % of recommended investigations | % of group who had all the recommended investigations |
| Pathological (group 1) (n=51) | 89 | 47 |
| Primary growth failure (n=28) | 88 | 39 |
| Secondary growth failure (n=23) | 89 | 57 |
| Unknown aetiology (group 2) (n=15) | 97 | 73 |
| Under active surveillance (n=12) | 97 | 75 |
| Lost to follow-up (n=3) | 93 | 67 |
| Non-pathological (group 3) (n=47) | 86 | 60 |
| FSS (n=29) | 83 | 53 |
| CDGP (n=18) | 91 | 72 |
| Normal (group 4) (n=26) | 82 | 41 |
| Normal stature (n=19) | 78 | 41 |
| Normal growth trajectory (n=7) | 94 | 43 |
| Total (n=139) | 87 | 53 |
CDGP, constitutional delay of growth and puberty; FSS, familial short stature.